Beneficial effects of ω-3 PUFA in children on cardiovascular risk factors during childhood and adolescence

Prostaglandins and Other Lipid Mediators

Volumn 120, Issue , 2015, Pages 72-79

  Bonafini, Sara ^a   Antoniazzi, Franco ^b   Maffeis, Claudio ^b   Minuz, Pietro ^a   Fava, Cristiano ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Cardiovascular risk factors; Children; Hypertension; Insulin resistance; Obesity; 3 PUFA

Indexed keywords

CYTOCHROME P450; ICOSANOID; OMEGA 3 FATTY ACID; OMEGA 3 POLYUNSATURED FATTY ACID; UNCLASSIFIED DRUG; FAT INTAKE;

ADOLESCENCE; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MEMBRANE; CHILDHOOD; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; OBESITY; SEA FOOD; ADOLESCENT; ADVERSE EFFECTS; ANIMAL; CARDIOVASCULAR DISEASES; CHILD; FAT INTAKE; PHARMACOLOGY; RISK FACTOR;

ADOLESCENT; ANIMALS; CARDIOVASCULAR DISEASES; CHILD; DIETARY FATS; FATTY ACIDS, OMEGA-3; HUMANS; RISK FACTORS;

EID: 84941808752     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.03.006     Document Type: Review

References (97)

1. G. Vannice, and H. Rasmussen Position of the academy of nutrition and dietetics: dietary fatty acids for healthy adults J Acad Nutr Diet 114 January (1) 2014 136 153
2. R. De Caterina n-3 fatty acids in cardiovascular disease N Engl J Med 364 June (25) 2011 2439 2450
3. W.S. Harris, M. Miller, A.P. Tighe, M.H. Davidson, and E.J. Schaefer Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives Atherosclerosis 197 March (1) 2008 12 24
4. K. Lane, E. Derbyshire, W. Li, and C. Brennan Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature Crit Rev Food Sci Nutr 54 5 2014 572 579
5. S.M. Ulven, B. Kirkhus, A. Lamglait, and et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers Lipids 46 January (1) 2011 37 46
6. J. Dyerberg, P. Madsen, J.M. Moller, I. Aardestrup, and E.B. Schmidt Bioavailability of marine n-3 fatty acid formulations Prostaglandins Leukot Essent Fatty Acids 83 September (3) 2010 137 141
7. J.P. Schuchardt, I. Schneider, H. Meyer, J. Neubronner, S.C. von, and A. Hahn Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil Lipids Health Dis 10 2011 145
8. V.R. Ramprasath, I. Eyal, S. Zchut, and P.J. Jones Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil Lipids Health Dis 12 2013 178
9. G. Barcelo-Coblijn, E.J. Murphy, R. Othman, M.H. Moghadasian, T. Kashour, and J.K. Friel Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid Am J Clin Nutr 88 September (3) 2008 801 809
10. J. Cao, K.A. Schwichtenberg, N.Q. Hanson, and M.Y. Tsai Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids Clin Chem 52 December (12) 2006 2265 2272
11. C.R. Harper, M.J. Edwards, A.P. DeFilippis, and T.A. Jacobson Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans J Nutr 136 January (1) 2006 83 87
12. N. Kaul, R. Kreml, J.A. Austria, and et al. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers J Am Coll Nutr 27 February (1) 2008 51 58
13. J.A. Tur, M.M. Bibiloni, A. Sureda, and A. Pons Dietary sources of omega 3 fatty acids: public health risks and benefits Br J Nutr 107 June (Suppl. 2) 2012 S23 S52
14. Y. Bao, J. Han, F.B. Hu, and et al. Association of nut consumption with total and cause-specific mortality N Engl J Med 369 November (21) 2013 2001 2011
15. P.M. Kris-Etherton, F.B. Hu, E. Ros, and J. Sabate The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms J Nutr 138 September (9) 2008 1746S 1751S
16. J. Sabate, K. Oda, and E. Ros Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials Arch Intern Med 170 May (9) 2010 821 827
17. R.U. Almario, V. Vonghavaravat, R. Wong, and S.E. Kasim-Karakas Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia Am J Clin Nutr 74 July (1) 2001 72 79
18. C. Westphal, A. Konkel, and W.H. Schunck CYP-eicosanoids - a new link between omega-3 fatty acids and cardiac disease? Prostaglandins Other Lipid Mediat 96 November (1-4) 2011 99 108
19. M. Wada, C.J. DeLong, Y.H. Hong, and et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products J Biol Chem 282 August (31) 2007 22254 22266
20. C.R. De Caterina, R. Madonna, R. Zucchi, and M.T. La Rovere Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside Am Heart J 146 September (3) 2003 420 430
21. D.Y. Oh, S. Talukdar, E.J. Bae, and et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects Cell 142 September (5) 2010 687 698
22. C. Arnold, A. Konkel, R. Fischer, and W.H. Schunck Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids Pharmacol Rep 62 May (3) 2010 536 547
23. H.N. Lee, and Y.J. Surh Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders Biochem Pharmacol 84 November (10) 2012 1340 1350
24. R. Fischer, A. Konkel, H. Mehling, and et al. Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway J Lipid Res 55 March (6) 2014 1150 1164
25. B. Lauterbach, E. Barbosa-Sicard, M.H. Wang, and et al. Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators Hypertension 39 February (2 (Pt 2)) 2002 609 613
26. D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.C. Lee, and M. VanRollins Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels J Pharmacol Exp Ther 303 November (2) 2002 768 776
27. A. Ulu, K.S. Stephen Lee, C. Miyabe, and et al. An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension J Cardiovasc Pharmacol 64 July (1) 2014 87 99
28. C. Morin, M. Sirois, V. Echave, R. Albadine, and E. Rousseau 17,18-epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase Am J Respir Cell Mol Biol 43 November (5) 2010 564 575
29. C. Arnold, M. Markovic, K. Blossey, and et al. Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids J Biol Chem 285 October (43) 2010 32720 32733
30. S.P. Caligiuri, H.M. Aukema, A. Ravandi, R. Guzman, E. Dibrov, and G.N. Pierce Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an alpha-linolenic acid-induced inhibition of soluble epoxide hydrolase Hypertension 64 July (1) 2014 53 59
31. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Lancet 354 August (9177) 1999 447 455
32. D. Mozaffarian, and E.B. Rimm Fish intake, contaminants, and human health: evaluating the risks and the benefits JAMA 296 October (15) 2006 1885 1899
33. W.S. Harris Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review J Lipid Res 30 June (6) 1989 785 807
34. Y. Park, and W.S. Harris Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance J Lipid Res 44 March (3) 2003 455 463
35. I.A. Brouwer, M.H. Raitt, C. Dullemeijer, and et al. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators Eur Heart J 30 April (7) 2009 820 826
36. A. Leaf, C.M. Albert, M. Josephson, and et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake Circulation 112 November (18) 2005 2762 2768
37. M.H. Raitt, W.E. Connor, C. Morris, and et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial JAMA 293 June (23) 2005 2884 2891
38. P.M. Kris-Etherton, W.S. Harris, and L.J. Appel Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 November (21) 2002 2747 2757
39. J. Steinberger, and S.R. Daniels Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism) Circulation 107 March (10) 2003 1448 1453
40. C.T. Damsgaard, K.D. Stark, M.F. Hjorth, and et al. n-3 PUFA status in school children is associated with beneficial lipid profile, reduced physical activity and increased blood pressure in boys Br J Nutr 110 October (7) 2013 1304 1312
41. C.T. Damsgaard, L. Schack-Nielsen, K.F. Michaelsen, M.B. Fruekilde, O. Hels, and L. Lauritzen Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants J Nutr 136 January (1) 2006 94 99
42. M.H. Pedersen, C. Molgaard, L.I. Hellgren, and L. Lauritzen Effects of fish oil supplementation on markers of the metabolic syndrome J Pediatr 157 September (3) 2010 395 400
43. L. Lauritzen, L.B. Harslof, L.I. Hellgren, M.H. Pedersen, C. Molgaard, and K.F. Michaelsen Fish intake, erythrocyte n-3 fatty acid status and metabolic health in Danish adolescent girls and boys Br J Nutr 107 March (5) 2012 697 704
44. M.R. Skilton, O.T. Raitakari, and D.S. Celermajer High intake of dietary long-chain omega-3 fatty acids is associated with lower blood pressure in children born with low birth weight: NHANES 2003-2008 Hypertension 61 May (5) 2013 972 976
45. M.R. Skilton, V. Mikkila, P. Wurtz, and et al. Fetal growth, omega-3 (n-3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The Cardiovascular Risk in Young Finns Study Am J Clin Nutr 97 January (1) 2013 58 65
46. R. Huxley, C.G. Owen, P.H. Whincup, and et al. Is birth weight a risk factor for ischemic heart disease in later life? Am J Clin Nutr 85 May (5) 2007 1244 1250
47. T.A. O'Sullivan, A.P. Bremner, L.J. Beilin, and et al. Polyunsaturated fatty acid intake and blood pressure in adolescents J Hum Hypertens 26 March (3) 2012 178 187
48. M. Asserhoj, S. Nehammer, J. Matthiessen, K.F. Michaelsen, and L. Lauritzen Maternal fish oil supplementation during lactation may adversely affect long-term blood pressure, energy intake, and physical activity of 7-year-old boys J Nutr 139 February (2) 2009 298 304
49. R.M. Martin, D. Gunnell, and G.D. Smith Breastfeeding in infancy and blood pressure in later life: systematic review and meta-analysis Am J Epidemiol 161 January (1) 2005 15 26
50. C.G. Owen, P.H. Whincup, J.A. Gilg, and D.G. Cook Effect of breast feeding in infancy on blood pressure in later life: systematic review and meta-analysis BMJ 327 November (7425) 2003 1189 1195
51. R.L. van, A.H. Wijga, J.C. de Jongste, and et al. Blood pressure in 12-year-old children is associated with fatty acid composition of human milk: the prevention and incidence of asthma and mite allergy birth cohort Hypertension 60 October (4) 2012 1055 1060
52. J.G. Ayer, J.A. Harmer, W. Xuan, and et al. Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: effects on blood pressure and arterial structure and function at age 8 y Am J Clin Nutr 90 August (2) 2009 438 446
53. N. Chahal, C. Manlhiot, H. Wong, and B.W. McCrindle Effectiveness of omega-3 polysaturated fatty acids (fish oil) supplementation for treating hypertriglyceridemia in children and adolescents Clin Pediatr (Phila) 53 March (7) 2014 645 651
54. S.D. de Ferranti, C.E. Milliren, E.R. Denhoff, and et al. Using high-dose omega-3 fatty acid supplements to lower triglyceride levels in 10- to 19-year-olds Clin Pediatr (Phila) 53 May (5) 2014 428 438
55. C. Juarez-Lopez, M. Klunder-Klunder, A. Madrigal-Azcarate, and S. Flores-Huerta Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents Pediatr Diabetes 14 August (5) 2013 377 383
56. E.J. Feskens, J.G. Loeber, and D. Kromhout Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study Am J Epidemiol 140 August (4) 1994 350 360
57. I. Thorsdottir, J. Hill, and A. Ramel Omega-3 fatty acid supply from milk associates with lower type 2 diabetes in men and coronary heart disease in women Prev Med 39 September (3) 2004 630 634
58. C.E. Friedberg, M.J. Janssen, R.J. Heine, and D.E. Grobbee Fish oil and glycemic control in diabetes. A meta-analysis Diabetes Care 21 April (4) 1998 494 500
59. H.M. Roche Fatty acids and the metabolic syndrome Proc Nutr Soc 64 February (1) 2005 23 29
60. T. Burrows, C.E. Collins, and M.L. Garg Omega-3 index, obesity and insulin resistance in children Int J Pediatr Obes 6 June (2-2) 2011 e532 e539
61. T. Decsi, H. Minda, R. Hermann, and et al. Polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of diabetic children Prostaglandins Leukot Essent Fatty Acids 67 October (4) 2002 203 210
62. M.R. Miller, X. Yin, J. Seifert, and et al. Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY) Pediatr Diabetes 12 December (8) 2011 669 675
63. M. Lopez-Alarcon, A. Martinez-Coronado, O. Velarde-Castro, E. Rendon-Macias, and J. Fernandez Supplementation of n3 long-chain polyunsaturated fatty acid synergistically decreases insulin resistance with weight loss of obese prepubertal and pubertal children Arch Med Res 42 August (6) 2011 502 508
64. V. Nobili, G. Bedogni, A. Alisi, and et al. Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial Arch Dis Child 96 April (4) 2011 350 353
65. V. Nobili, A. Alisi, C.C. Della, and et al. Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children Nutr Metab Cardiovasc Dis 23 November (11) 2013 1066 1070
66. I.S. Jang, D.Y. Hwang, K.R. Chae, and et al. Role of dietary fat type in the development of adiposity from dietary obesity-susceptible Sprague-Dawley rats Br J Nutr 89 March (3) 2003 429 438
67. A.M. Hill, J.D. Buckley, K.J. Murphy, and P.R. Howe Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors Am J Clin Nutr 85 May (5) 2007 1267 1274
68. M. Kabir, G. Skurnik, N. Naour, and et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study Am J Clin Nutr 86 December (6) 2007 1670 1679
69. S.M. Donahue, S.L. Rifas-Shiman, D.R. Gold, Z.E. Jouni, M.W. Gillman, and E. Oken Prenatal fatty acid status and child adiposity at age 3 years: results from a US pregnancy cohort Am J Clin Nutr 93 April (4) 2011 780 788
70. S. Groh-Wargo, J. Jacobs, N. Auestad, D.L. O'Connor, J.J. Moore, and E. Lerner Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: a prospective, randomized, controlled trial Pediatr Res 57 May (5 (Pt 1)) 2005 712 718
71. A.S. Ryan, M.B. Montalto, S. Groh-Wargo, and et al. Effect of DHA-containing formula on growth of preterm infants to 59 weeks postmenstrual age Am J Hum Biol 11 4 1999 457 467
72. I.B. Helland, L. Smith, B. Blomen, K. Saarem, O.D. Saugstad, and C.A. Drevon Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age Pediatrics 122 August (2) 2008 e472 e479
73. S.M. Innis, D.H. Adamkin, R.T. Hall, and et al. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula J Pediatr 140 May (5) 2002 547 554
74. K. Kennedy, S. Ross, E.B. Isaacs, and et al. The 10-year follow-up of a randomised trial of long-chain polyunsaturated fatty acid supplementation in preterm infants: effects on growth and blood pressure Arch Dis Child 95 August (8) 2010 588 595
75. C. de Jong, G. Boehm, H.K. Kikkert, and M. Hadders-Algra The Groningen LCPUFA study: no effect of short-term postnatal long-chain polyunsaturated fatty acids in healthy term infants on cardiovascular and anthropometric development at 9 years Pediatr Res 70 October (4) 2011 411 416
76. H. Hauner, D. Much, C. Vollhardt, and et al. Effect of reducing the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: an open-label randomized controlled trial Am J Clin Nutr 95 February (2) 2012 383 394
77. S. Scholtens, A.H. Wijga, H.A. Smit, and et al. Long-chain polyunsaturated fatty acids in breast milk and early weight gain in breast-fed infants Br J Nutr 101 January (1) 2009 116 121
78. H.E. Bays Safety considerations with omega-3 fatty acid therapy Am J Cardiol 99 March (6A) 2007 35C 43C
79. D. Mozaffarian Fish, mercury, selenium and cardiovascular risk: current evidence and unanswered questions Int J Environ Res Public Health 6 June (6) 2009 1894 1916
80. N.C. Ward, I.J. Tsai, A. Barden, and et al. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure Hypertension 51 May (5) 2008 1393 1398
81. A.W. Dreisbach, S. Japa, A. Sigel, and et al. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension Am J Hypertens 18 October (10) 2005 1276 1281
82. C. Fava, M. Montagnana, P. Almgren, and et al. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure Hypertension 52 August (2) 2008 373 380
83. C. Fava, M. Montagnana, E. Danese, and et al. Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes Pharmacogenet Genomics 20 February (2) 2010 94 103
84. C. Fava, M. Montagnana, P. Almgren, and et al. The common functional polymorphism-50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes J Hypertens 28 February (2) 2010 294 299
85. C. Fava, M. Montagnana, E. Danese, and et al. The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes Prostaglandins Other Lipid Mediat 98 May (1-2) 2012 31 36
86. J.V. Gainer, A. Bellamine, E.P. Dawson, and et al. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension Circulation 111 January (1) 2005 63 69
87. L.M. King, J.V. Gainer, G.L. David, and et al. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension Pharmacogenet Genomics 15 January (1) 2005 7 13
88. M. Spiecker, H. Darius, T. Hankeln, and et al. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 Circulation 110 October (15) 2004 2132 2136
89. A. Bouchard-Mercier, I. Rudkowska, S. Lemieux, P. Couture, and M.C. Vohl Polymorphisms in genes involved in fatty acid beta-oxidation interact with dietary fat intakes to modulate the plasma TG response to a fish oil supplementation Nutrients 6 3 2014 1145 1163
90. A. AlSaleh, Z. Maniou, F.J. Lewis, W.L. Hall, T.A. Sanders, and S.D. O'Dell Interaction between a CSK gene variant and fish oil intake influences blood pressure in healthy adults J Nutr 144 March (3) 2014 267 272
91. C. Ouellette, H. Cormier, I. Rudkowska, and et al. Polymorphisms in genes involved in the triglyceride synthesis pathway and marine omega-3 polyunsaturated fatty acid supplementation modulate plasma triglyceride levels J Nutrigenet Nutrigenomics 6 4-5 2013 268 280
92. H. Cormier, I. Rudkowska, E. Thifault, S. Lemieux, P. Couture, and M.C. Vohl Polymorphisms in fatty acid desaturase (FADS) gene cluster: effects on glycemic controls following an omega-3 polyunsaturated fatty acids (PUFA) supplementation Genes (Basel) 4 3 2013 485 498
93. H. Cormier, I. Rudkowska, A.M. Paradis, and et al. Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation Nutrients 4 August (8) 2012 1026 1041
94. S. Hellstrand, E. Sonestedt, U. Ericson, and et al. Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C J Lipid Res 53 June (6) 2012 1183 1189
95. J. Dumont, I. Huybrechts, A. Spinneker, and et al. FADS1 genetic variability interacts with dietary alpha-linolenic acid intake to affect serum non-HDL-cholesterol concentrations in European adolescents J Nutr 141 July (7) 2011 1247 1253
96. Y. Lu, E.J. Feskens, M.E. Dolle, and et al. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study Am J Clin Nutr 92 July (1) 2010 258 265
97. K.A. Volcik, J.A. Nettleton, C.M. Ballantyne, and E. Boerwinkle Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study Am J Clin Nutr 87 June (6) 2008 1926 1931